WuXi Biologics CEO expects approval for Covid-19 antibody treatment 'late this year or early next year'
November 18, 2020 at 21:11 PM EST
WuXi Biologics has signed more than 10 deals with clients to research antibodies that can potentially deliver treatment for the coronavirus.
